Part 3 – MSN QCDR Measures

doctor with gloves looking at chart MIPS QCDR measures
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

MSN QCDR Measures - 2021

MIPS Series: part 3 of 4

By:

  • Barbara Rubel, MBA, FRBMA, MSN Sr. VP, Marketing and Client Services
  • Claudia Murray, RCC, MSN Sr. VP, Regulatory Affairs and Corporate Compliance Officer

QCDR Measures: MSN’s current offerings – 2021

MSN currently offers the following 10, non-national measures that have been approved by CMS for the performance year 2021.  They will be available for licensing by other QCDRs in 2022.

  • #MSN13: Screening Coronary Calcium Scoring for Cardiovascular Risk Assessment Including Coronary Artery Calcification Regional Distribution Scoring (no benchmark in 2021 – 3 points) this measure may establish a benchmark for 2020 and 2021 during 2020 scoring

     

  • #MSN15: Use of Thyroid Imaging Reporting & Data System (TI-RADS) in Final Report to Stratify Thyroid Nodule Risk (no benchmark in 2021 – 3 points plus 1 HP bonus point) this measure will most likely establish a benchmark for 2020 and 2021 during 2020 scoring

     

  • #MSN16: Screening Abdominal Aortic Aneurysm Reporting with Recommendations (no benchmark in 2021 – 3 points plus 1 HP bonus point) CMS made us revamp this one but it should establish a benchmark in 2021

     

  • #QMM16: IVC Filter Management Confirmation (no benchmark in 2021 – 3 points plus 1 HP bonus point) this measure will most likely establish a benchmark for 2021 during 2021 scoring

     

  • #QMM17: Appropriate Follow-up Recommendations for Ovarian-Adnexal Lesions using the Ovarian-Adnexal Reporting and Data System (O-RADS) (no benchmark in 2021 -3 points plus 1 HP bonus point) some practices do not like this measure, so adoption has been slow

     

  • #QMM18: Use of Breast Cancer Risk Score on Mammography – no benchmark in 2021 (3 points plus 1 HP bonus point) this measure may establish a benchmark for 2021 during 2021 scoring

     

  • #QMM19: DEXA/DXA and Fracture Risk Assessment for Patients with Osteopenia (no benchmark in 2021 – 3 points) this measure will most likely establish a benchmark for 2021 during 2021 scoring

     

  • #QMM20: Opening Pressure in Lumbar Puncture (no benchmark in 2021 – 3 points) this measure may establish a benchmark for 2021 during 2021 scoring

     

  • #MEDNAX55: Use of ASPECTS (Alberta Stroke Program Early CT Score) for non-contrast CT Head performed for suspected acute stroke (no benchmark in 2021 – 3 points) this measure will most likely establish a benchmark for 2021 during 2021 scoring

     

  • #QUANTUM31: Central Line Ultrasound Guidance (10 points + 1 bonus HP bonus point) this measure is topped out in 2021 and may be devalued in 2022 or deleted

Want to know more? 

Want to know more about MSN’s QCDR measures? 
View our:

MIPS Article Series

This article is #3 of 4 in our MIPS series. Be sure to check out the rest of the articles in the series: 

Barbara Rubel MBA, FRBMA Senior Vice President, Marketing & Client Services

Barbara Rubel MBA, FRBMA Senior Vice President, Marketing & Client Services

Barbara has been a leader with MSN Client Services since 1998. Her extensive background in strategic planning, market research, healthcare marketing and managed care negotiations provide a wealth of information to support MSN Clients.

Barbara has also been highly involved in industry organizations, serving as President of the Radiology Business Management Association (RBMA), the Georgia RBMA, and the Florida RBMA. In addition, she chaired the influential RBMA Federal Affairs Committee and the RBMA Technology Task force and was a member of the RBMA Data Committee. Her work on behalf of radiology has earned her the RBMA Special Recognition Award (2010), the RBMA Global Achievement Award (2013), and she is a Fellow of the RBMA.

Claudia Murray, RCC Senior Vice President of Regulatory Affairs Executive,  Director of Quality Payment Programs

Claudia brings an extensive background in Medicare regulations, law and billing processes having spent more than 20 years with the Medicare program in various roles. Prior to joining MSN Healthcare Solutions as their full-time compliance officer, Claudia headed a small consulting firm specializing in radiology and other hospital-based specialties. She consulted with MSN for 15 years in designing, implementing and advising on their compliance programs.

Currently at MSN, Claudia is responsible for the myriad activities for HIPAA and corporate compliance as well as the Quality Payment Programs, bringing her full circle to CMS regulations and programs.

Claudia Murray RCC Senior Vice President of Regulatory Affairs Executive Director of Quality Payment Programs